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Abstract 
Thymosin 84 forms a 1: 1 complex with actin and thereby prevents polymerization. Rapid formation of filaments from this complex was observed, 
however, when actin trimers were added. Polymerization can likewise be initiated by the addition of one equivalent of phalloidin or, less effectively, 
cytochalasin B. Since both toxins, which reportedly support nucleation, have similar effects as the covalently linked actin trimers, it appears that 
the formation of filaments from the actin-thymosin /I4 complex depends on the availability of stable actin nuclei. Remarkably, rapid polymerization 
was also observed if small amounts of myosin Sl were added, suggesting that also myosin, a protein functionally connected with polymeric actin, 
can serve as a nucleation center. Considering the existence of thymosin 84 and related peptides in numerous mammalian tissues, our data suggest 
that spontaneous formation of microfilaments in non-muscle cells may be regulated at the level of nucleation. Uncontrolled polymerization induced 
by the formation of phalloidin-stabilized nuclei may explain the acute toxic effects of phalloidin in hepatocytes. 
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1. Introducdon 
In non-muscle cells a considerable part of actin exists 
in the monomeric state [ 11. Under the ionic conditions of 
the cell, high concentrations of monomeric actin require 
sequestration by proteins like profllin [2] or actobindin 
[3]. Since the detection of Safer and coworkers [4,5] that 
non-muscle cells contain a 5 kDa peptide, thymosin 84, 
that is likewise able to prevent actin polymerization, ev- 
idence has been growing that at least in some tissues 
sequestration by thymosin 84 may be of physiological 
importance [6-lo]. 
It has been reported that in some kinds of cells 
hormones [ll] or chemotactic peptides [6] can lead to 
spontaneous formation of microfiiaments. So far, neither 
the regulation of this process nor the nature of the com- 
plex from which the filaments arise, is known. From 
experiments with model systems it has been speculated 
that differences in the rate of nucleotide exchange in 
complexes of actin with proGlin, or thymosin 84, may 
provide the basis for regulated polymerization [12]. 
Other arguments uggest hat regulation may depend on 
the different al?inities of the actin-thymosin 84 complex 
for ATP and ADP [13], or on the oxidation of the 
methionine residue in position 6 of thymosin 84 which 
strongly decreases the polymerization-inhibiting capac- 
ity of thymosin j34 (unpublished results). Our present 
data suggest hat spontaneous polymerization from the 
thymosin 84 complex may simply depend on the availa- 
bility of stable actin nuclei. 
*Corresponding author. Fax: (49) (6221) 48-6351. 
2. Materials and methods 
2.1. Protein purification 
Actin was prepared as described by Spudich and Watt [14] and 
further purified by a gel-filtration step on a Fractogel TSK HW 55 
(Merck, Darmstadt) column (3 x 120 cm) in buffer G (2 mM Tris, 0.2 
mM ATP, 0.1 mM CaClr, 0.02% NaN,, pH 7.8). 
Chemically crosslinked actin trimers (nuclei) were obtained from 
F-actin by the addition of a 2-fold excess of N,11”-p-phenylene-bis- 
maleimide at pH 9.2 for 15 min and purified according to La1 et al. [15]. 
Myosin Sl was prepared according to Weeds and Taylor [16]. 
Thymosin 84 was isolated from bovine lungs following a procedure 
described for the isolation of the peptides from bovine tissue [17]. 
Purification was achieved using preparative iso-electric focussing and 
semipreparative HPLC on RP18 (Parcosil Pro RP 30&5, Cls, Biotek). 
2.2. Fluorescence measurements 
Polymerization was monitored by pyrenyl fluorescence [18], using a 
10 mM solution of actin, containing 5% pyrenyl actin (excitation 366 
nm; emmission 406 mn). Equimolar amounts of thymosin /I4 were 
added and incubated for 30 min before the polymerization was started 
by adding 0.1 M KCl. Phalloidin, myosin Sl or nuclei were added 
simultaneously with the salt. 
2.3. Viscosimetric measurements 
Polymerization was monitored in a Cannon capillary viscosimeter, 
using a 10 PM concentration of G-actin in buffer G to which KC1 was 
added to a final concentration of 100 mM. For investigating the nucle- 
ation effect in actin-thymosin 84 solutions, thymosin 84 was added to 
the actin to a llnal concentration of 10 ,uM (1 : 1) and allowed to stand 
for 30 min at RT before polymerization was started. After 30 min 
incubation under polymerization conditions, phalloidin, actin nuclei, 
myosin Sl or cytochalasin B were added. In control assays with un- 
complexed actin the nucleation factors were added together with KCl. 
3. Results and discussion 
It has been reported from several laboratories that 
when complexed with thymosinjI4 muscle actin is unable 
to polymerize [6-lo]. Nonetheless, in a 10 ,uM solution 
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Fig. 1. Polymerization of actin (10 PM) with 100 mM KC1 followed by 
fluorescence (5% pyrenyl actin) in the presence of thymosin 84 
(1 equiv.) (a); thymosin 84 (1 equiv.) plus phalloidin (1 equiv.) (b); 
phalloidin (1 equiv.) (c). 
of muscle actin and thymosin j34 in a ratio 1 : 1, poly- 
meric actin is formed at a very low rate upon the addition 
of 0.1 M KCl, as shown by fluorescence measurement 
(5% pyrenyl actin) (Fig. 1). This is most simply explained 
as reflecting the polymerization of that amount of actin 
that according to the & (ca. 1 PM) is present in the 
uncomplexed state [ 19,201. If to this solution one equiva- 
lent of phalloidin is added, the rate of polymerization is 
strongly enhanced, and the extent of polymerization 
reaches that of normal actin, as shown in Fig. 1. The 
effect of phalloidin could be confirmed by viscometry 
measurements (Fig. 2). Here, the actin-thymosin 84 
complex was pretreated with 0.1 M KC1 for 30 min be- 







Fig. 2. Polymerization kinetics of actin-thymosin 84 (1 : 1) measured 
by capillary viscometry after the addition of 100 mM KC1 at time zero, 
without phalloidin (0) and with 1 equiv. of phalloidin (v). Phalloidin 
was added (t) 30 min after the addition of KC1 showing that in the 
absence of the toxin polymerization did not occur within this time. For 
comparison: pure actin with 1 equiv. of phalloidin (o), added together 










Fig. 3. Polymerization of actin-thymosin /34 upon the addition of var- 
ious concentrations of actin nuclei followed by fluorescence. Actin and 
thymosin /J4 (1 : 1) were incubated for 30 min before different amounts 
of nuclei were added together with 100 mM KCl. No nuclei added (a); 
2.52, 546, 7.5% and 10% nuclei added, respectively (be). 
toxin caused a steep increase in both the rate and the 
absolute amount of polymerization. 
It is generally agreed that the effect of phalloidin is to 
stabilize actin filaments [21]. From polymerization ex- 
periments in which phalloidin caused a distinct accelera- 
tion of the rate of polymerization [22] it was concluded 
that the stabilization effect observed for filaments would 
apply for actin nuclei as well. In accordance with these 
findings, the most likely explanation for the instant onset 
of polymerization in solutions containing the actin-thy- 
mosin /34 complex is the increase in the concentration of 
actin nuclei, due to their stabilization by phalloidin. 
In order to substantiate our suggestion that nuclei 
might be involved in the phalloidin-accelerated polymer- 
ization we prepared actin trimers by reacting F-actin 
with iV-K-p-phenylene-bis-maleimide according to La1 
et al. [15]. As proved by SDS-PAGE, our preparation 
consisted of ca. 50% of actin trimers, ca. 45% monomers 
and traces of dimers (data not shown). Addition of these 
nuclei (5% of total actin) to the actin-thymosin 84 com- 
plex accelerated polymerization at a rate even higher 
than that observed by the addition of phalloidin (Fig. 3). 
The acceleration depended on the amount of nuclei 
added, but not in a linear way. The increase in the polym- 
erization rate upon the addition of actin nuclei was also 
confirmed by viscometry measurements (Fig. 4). 
It has been reported that one effect of cytochalasin B 
on actin is to accelerate polymerization by nucleation 
[23,24]. We confirmed this effect (Fig. 5) by showing that 
in the presence of cytochalasin B the typical lag phase in 
the polymerization kinetics of actin was absent. When 
cytochalasin B was added to a solution of actin-thy- 
mosin 84, the toxin accelerated the polymerization also 
from the complex, although to a much smaller extent 
than when phalloidin or nuclei were added. Although 
quantitatively small in size, the effect of cytochalasin B 
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Fig. 4. Polymerization of actin and act&thymosin 84 (1:l) upon the 
addition of actin nuclei followed by viscometry. Nuclei (5%) were added 
Fig. 5. Polymerization kinetics of actin (o,*) and actin-thymosin 84 
(o,o) upon the addition of cytochalasin B (1 equiv.) followed by viscom- 
to actin (0) together with 100 mM KC1 at time zero, or to actin- etry. Actin with (e) or without (0) cytochalasin B, added together with 
thymosin 84 (1 : 1) (v) (1) 30 min after the addition of 100 mM KC1 100 mM KC1 at time zero. Actin-thymosin/?4 with (0) or without (0) 
showing that in the absence of nuclei polymerization did not occur cytochalasin B. Cytochalasin B was added (1) 30 min after the addition 
within this time. For comparison: actin-thymosin 84 without added of 100 mM KC1 showing that in the absence of the toxin polymerization 
nuclei (0). did not occur within this time. 
supports the idea that formation of nuclei is the crucial 
event for initiating spontaneous polymerization from the 
actin-thymosin 84 complex. 
It is known that myosin Sl is able to induce actin 
polymerization even under non-polymerizing conditions 
[25]. We therefore tested the effect of myosin Sl on a 
thymosin 84 inhibited actin solution by fluorescence and 
viscometry. Myosin Sl was added either simultaneously 
with 0.1 M KC1 to the fluorescence assay (Fig. 6), or, 
after 30 min pretreatment with the salt, to the viscosime- 
ter (Fig. 7). In both systems the addition of 10% myosin 
S 1 caused the steepest increase in the rates of polymeriza- 
tion that we observed. Also here, the effect depended on 
the concentration. These experiments how that not only 
actin nuclei can serve as nucleation centers, but that this 
function can likewise be exhibited by a protein that is 
functionally connected with the polymeric form of actin. 
While the experiments with phalloidin, cytochalasin B 
or covalently linked actin trimers represent non-physio- 
logical conditions, the experiments using myosin Sl are 
considered to be closest to the physiological situation. 
Anticipating that myosin itself has the same activity as 
the fragment and that thymosin /?4 complexation is the 
predominant mechanism for inhibiting uncontrolled fila- 
ment formation in non-muscle cells, our data open the 
possibility that cells can organize the formation of fla- 
ments from their pool of complexed monomeric actin 
simply by activating myosin at locations where the con- 
tractile machinery is required. Other nucleation centers 
of different structure and function may exist, and it can- 
not be excluded that cells may contain a component 
representing a physiological equivalent of phalloidin en- 
gaged in regulating filament formation. More arguments 
for the involvement of nuclei as organization centers of 
microfilaments are based on the identification of the 
ActA-protein of Listeria monocytogenes that induces the 
formation of a tail of polymerized actin on which the 
bacterium is propelled through the infected cell [26], as 
well as from the proposal that capped ends may serve as 
nucleation centers [27]. 
Cytotoxic effects of phalloidin have mainly been stud- 
ied in hepatocytes ince these cells possess a phallotoxin- 
transporting activity in their plasma membrane [28-301. 
In freshly isolated rat hepatocytes the addition of phal- 
loidin causes the formation of surface blebs within ca. 10 
min [31]. Considering the reported filament stabilization 
of phalloidin that leads to a decrease in critical concen- 
tration of actin in vitro [22,32], the morphological 
changes in the hepatocytes were interpreted in terms of 
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Fig. 6. Polymerization of actin-thymosin 84 with 100 mM KC1 in the 
presence of various amounts of myosin Sl followed by fluorescence. 
Actin and thymosin /34 (1 : 1) were incubated for 30 min before myosin 
Sl was added together with the salt. Without myosin Sl (a); with 5% 
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Fig. 7. Polymerization of actin-thymosin 84 (1 : 1) upon the addition 
of various amounts of myosin Sl, followed by viscometry. Myosin Sl 
(5% (0); 10% (0)) was added after 30 min incubation of actin-thymosin 
84 in the presence of 100 mM KCI. 
delayed filament turnover. However, lack of actin mono- 
mers as a consequence of inhibited filament depolymeri- 
zation might be expected to lead to long-term effects, but 
not to the formation of these blebs within a few minutes. 
On the other hand, the kinetics of polymerization of 
thymosin /?4 stabilized muscle actin by phalloidin are 
well consistent with this time scale. We therefore believe 
that formation of phalloidin-stabilized nuclei is the most 
likely mechanism to explain the phalloidin effect in iso- 
lated hepatocytes. This would imply, of course, that also 
in hepatocytes the pool of monomeric actin is stabilized 
by thymosinj?4, a possibility for which evidence has been 
provided recently [33]. A similar effect of phalloidin on 
the actin-profilin complex has so far not been reported. 
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